GL-V9 exerts anti-T cell malignancies effects via promoting lysosome-dependent AKT1 degradation and activating AKT1/FOXO3A/BIM axis.
暂无分享,去创建一个
Xiangyuan Wang | Q. Guo | R. Tan | H. Hui | Hui Li | Xiao Liu | Jingyan Xu | Po Hu | Xiaoxuan Yu | Yingjie Qing | Zhanyu Wang | Hongzheng Wang | Mengyuan Zhu